HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

Executive Summary

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.
Advertisement

Related Content

Canadian Authorities Say Some Cosmetic Talc Applications May Endanger Human Health
J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Trump's Chinese Import Tariff Hike Could Take Toll On Consumer Health Sector
J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients
J&J Hopes To Continue Appellate Streak Following Whopping $4.69bn Talc Verdict
J&J Consumer Health On Solid Footing With Help From Personal Care Sales

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel